Correlation Between Materials Portfolio and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Materials Portfolio and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Materials Portfolio and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Materials Portfolio Fidelity and Biotechnology Fund Class, you can compare the effects of market volatilities on Materials Portfolio and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Materials Portfolio with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Materials Portfolio and Biotechnology Fund.
Diversification Opportunities for Materials Portfolio and Biotechnology Fund
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Materials and Biotechnology is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Materials Portfolio Fidelity and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Materials Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Materials Portfolio Fidelity are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Materials Portfolio i.e., Materials Portfolio and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Materials Portfolio and Biotechnology Fund
Assuming the 90 days horizon Materials Portfolio Fidelity is expected to generate 0.31 times more return on investment than Biotechnology Fund. However, Materials Portfolio Fidelity is 3.23 times less risky than Biotechnology Fund. It trades about -0.19 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about -0.07 per unit of risk. If you would invest 10,113 in Materials Portfolio Fidelity on October 20, 2024 and sell it today you would lose (1,418) from holding Materials Portfolio Fidelity or give up 14.02% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Materials Portfolio Fidelity vs. Biotechnology Fund Class
Performance |
Timeline |
Materials Portfolio |
Biotechnology Fund Class |
Materials Portfolio and Biotechnology Fund Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Materials Portfolio and Biotechnology Fund
The main advantage of trading using opposite Materials Portfolio and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Materials Portfolio position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.Materials Portfolio vs. Mid Cap 15x Strategy | Materials Portfolio vs. Nasdaq 100 2x Strategy | Materials Portfolio vs. Nasdaq 100 2x Strategy | Materials Portfolio vs. Ashmore Emerging Markets |
Biotechnology Fund vs. Wcm Focused Emerging | Biotechnology Fund vs. Delaware Emerging Markets | Biotechnology Fund vs. Dow 2x Strategy | Biotechnology Fund vs. Inverse Nasdaq 100 Strategy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |